DEA schedule
Is oxymorphone a controlled substance?
Federal schedule for oxymorphone from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Oxymorphone is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Oxymorphone (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted oxymorphone?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 27 prescription listings from 9 labelers, all Schedule II |
| DEA controlled substances list | Oxymorphone: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Oxymorphone | 9652 | II | Yes | Numorphan | Listed by name |
Oxymorphone NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 0054-0284 | Oxymorphone Hydrochloride | tablet | 10 mg/1 | Hikma Pharmaceuticals USA Inc. | CII |
| 10702-071 | Oxymorphone Hydrochloride | tablet | 10 mg/1 | KVK-Tech, Inc. | CII |
| 13107-104 | Oxymorphone Hydrochloride | tablet | 10 mg/1 | Aurolife Pharma, LLC | CII |
| 31722-930 | OXYMORPHONE HYDROCHLORIDE | tablet | 10 mg/1 | Camber Pharmaceuticals, Inc | CII |
| 42806-331 | Oxymorphone Hydrochloride | tablet | 10 mg/1 | Epic Pharma, LLC | CII |
| 72865-131 | OXYMORPHONE HYDROCHLORIDE | tablet | 10 mg/1 | XLCare Pharmaceuticals, Inc. | CII |
| 0054-0283 | Oxymorphone Hydrochloride | tablet | 5 mg/1 | Hikma Pharmaceuticals USA Inc. | CII |
| 10702-070 | Oxymorphone Hydrochloride | tablet | 5 mg/1 | KVK-Tech, Inc. | CII |
| 13107-103 | Oxymorphone Hydrochloride | tablet | 5 mg/1 | Aurolife Pharma, LLC | CII |
| 31722-929 | OXYMORPHONE HYDROCHLORIDE | tablet | 5 mg/1 | Camber Pharmaceuticals, Inc | CII |
| 42806-330 | Oxymorphone Hydrochloride | tablet | 5 mg/1 | Epic Pharma, LLC | CII |
| 63629-1926 | OXYMORPHONE HYDROCHLORIDE | tablet | 5 mg/1 | Bryant Ranch Prepack | CII |
| 72865-130 | OXYMORPHONE HYDROCHLORIDE | tablet | 5 mg/1 | XLCare Pharmaceuticals, Inc. | CII |
| 0115-1232 | Oxymorphone hydrochloride | tablet, film coated, extended release | 10 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 64896-697 | Oxymorphone hydrochloride | tablet, film coated, extended release | 10 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 0115-1316 | Oxymorphone hydrochloride | tablet, film coated, extended release | 15 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 64896-698 | Oxymorphone hydrochloride | tablet, film coated, extended release | 15 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 0115-1233 | Oxymorphone hydrochloride | tablet, film coated, extended release | 20 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 64896-699 | Oxymorphone hydrochloride | tablet, film coated, extended release | 20 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 0115-1317 | Oxymorphone hydrochloride | tablet, film coated, extended release | 30 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 64896-700 | Oxymorphone hydrochloride | tablet, film coated, extended release | 30 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 0115-1234 | Oxymorphone hydrochloride | tablet, film coated, extended release | 40 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 64896-701 | Oxymorphone hydrochloride | tablet, film coated, extended release | 40 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 0115-1231 | Oxymorphone hydrochloride | tablet, film coated, extended release | 5 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 64896-695 | Oxymorphone hydrochloride | tablet, film coated, extended release | 5 mg/1 | Amneal Pharmaceuticals LLC | CII |
| 0115-1315 | Oxymorphone hydrochloride | tablet, film coated, extended release | 7.5 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 64896-696 | Oxymorphone hydrochloride | tablet, film coated, extended release | 7.5 mg/1 | Amneal Pharmaceuticals LLC | CII |
Questions
Is oxymorphone a controlled substance?
Yes. Oxymorphone is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Oxymorphone (Schedule II).
Is oxymorphone a narcotic?
Yes. The DEA list marks oxymorphone as a narcotic (NARC = Y) and places it in Schedule II. Its FDA established pharmacologic class is Opioid Agonist.
What schedule is oxymorphone?
Oxymorphone is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.